Sir John BellAcademic

Biography

Professor Sir John Bell CH GBE FRS is a Canadian-British immunologist and geneticist who served as Regius Professor of Medicine at the University of Oxford from 2002 to March 2024, one of the most senior medical chairs in the UK. He founded the Wellcome Trust Centre for Human Genetics at Oxford in 1993 and served as President of the Academy of Medical Sciences from 2006 to 2011. He authored the 2017 UK Life Sciences Industrial Strategy and the 2021 Life Sciences Vision, shaping government policy on NHS–industry collaboration, clinical trials, and the UK's life sciences sector. During the Covid-19 pandemic he advised the UK government on national testing strategy and played a major role in the development and roll-out of the Oxford-AstraZeneca vaccine. From April 2024 he served as President of the Ellison Institute of Technology Oxford, stepping down in August–September 2025. He was knighted in 2015 and appointed Companion of Honour in the 2023 King's Birthday Honours for services to medicine, medical research, the life science industry, and public health.

References

1. 1.Regius Professor of Medicine, Sir John Bell, to step down from Oxford role | Oxford University — Confirms stepping down as Regius Professor in March 2024 to become President of EIT Oxford; background on career, Covid-19 advisory roles, and honours
2. 2.Life Sciences Industrial Strategy – A report to the Government from the life sciences sector (2017) — Establishes Sir John Bell as author of the 2017 Life Sciences Industrial Strategy
3. 3.Birthday Honours List 2023 – PM List Transparency Data | GOV.UK — Confirms appointment as Companion of Honour in 2023 for services to Medicine, Medical Research, the Life Science Industry and Public Health
4. 4.Professor Sir John Bell steps down as president of the Ellison Institute of Technology | Insider Media

Expertise

Cited on

• Hospital discharge / bed-blocking

Stated areas of expertise

• Life sciences industrial strategy
• NHS–industry collaboration
• Genomics and precision medicine
• Vaccine development and pandemic response
• Translational research
• Health innovation policy

Notable achievements

• Authored the 2017 Life Sciences Industrial Strategy — a report to government providing recommendations to make the UK the leading global hub for life sciences investment and NHS collaboration. Source ↗
• Appointed Companion of Honour in the 2023 King's Birthday Honours for services to Medicine, Medical Research, the Life Science Industry and Public Health. Source ↗
• During the Covid-19 pandemic, played a major role in enabling the development of lateral flow testing platforms, a national testing programme, and the roll-out of the Oxford-AstraZeneca vaccine. Source ↗
• Founded the Wellcome Trust Centre for Human Genetics at Oxford in 1993, one of the world's leading centres for complex trait common disease genetics. Source ↗
• Was crucial in creating Genomics England, UK Biobank, and Our Future Health. Source ↗

What they’ve said

• “they're not going to do any more investing in the UK”

  former regius professor of medicine at the University of Oxford · Hospital discharge / bed-blocking · 27 Aug 2026 · Big pharma will stop investing in UK, top scientist warns after Merck’s £1bn exit ↗

• “Industry bosses had told him that they see Britain as a poor bet. They demand more subsidies, higher drug-price caps and fast NHS approval for expensive new biopharma treatments.”

  Oxford's former regius professor of medicine · Hospital discharge / bed-blocking · 27 Aug 2026 · The Guardian view on Merck’s exit: Britain’s biopharma strategy stalls in the face of China’s rise | Editorial ↗

Source references

1. Big pharma will stop investing in UK, top scientist warns after Merck’s £1bn exittheguardian.com · 27 Aug 2026
2. The Guardian view on Merck’s exit: Britain’s biopharma strategy stalls in the face of China’s rise | Editorialtheguardian.com · 27 Aug 2026

Contact & links

• Staff pagehttps://acmedsci.ac.uk/about/governance/academy-president/professor-sir-john-bell
• Staff pagehttps://royalsociety.org/people/john-bell-11067/

Organisational contact points only, each taken from a page the organisation publishes itself. No personal or direct contact details are held or shown.